1. Home
  2. SLRN vs SIBN Comparison

SLRN vs SIBN Comparison

Compare SLRN & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRN
  • SIBN
  • Stock Information
  • Founded
  • SLRN 2020
  • SIBN 2008
  • Country
  • SLRN United States
  • SIBN United States
  • Employees
  • SLRN N/A
  • SIBN N/A
  • Industry
  • SLRN Biotechnology: Pharmaceutical Preparations
  • SIBN Medical/Dental Instruments
  • Sector
  • SLRN Health Care
  • SIBN Health Care
  • Exchange
  • SLRN Nasdaq
  • SIBN Nasdaq
  • Market Cap
  • SLRN 485.6M
  • SIBN 557.9M
  • IPO Year
  • SLRN 2023
  • SIBN 2018
  • Fundamental
  • Price
  • SLRN $4.37
  • SIBN $12.34
  • Analyst Decision
  • SLRN Buy
  • SIBN Strong Buy
  • Analyst Count
  • SLRN 6
  • SIBN 7
  • Target Price
  • SLRN $11.50
  • SIBN $23.43
  • AVG Volume (30 Days)
  • SLRN 463.0K
  • SIBN 510.1K
  • Earning Date
  • SLRN 11-13-2024
  • SIBN 11-12-2024
  • Dividend Yield
  • SLRN N/A
  • SIBN N/A
  • EPS Growth
  • SLRN N/A
  • SIBN N/A
  • EPS
  • SLRN N/A
  • SIBN N/A
  • Revenue
  • SLRN N/A
  • SIBN $157,035,000.00
  • Revenue This Year
  • SLRN N/A
  • SIBN $21.87
  • Revenue Next Year
  • SLRN N/A
  • SIBN $17.34
  • P/E Ratio
  • SLRN N/A
  • SIBN N/A
  • Revenue Growth
  • SLRN N/A
  • SIBN 18.98
  • 52 Week Low
  • SLRN $3.36
  • SIBN $11.76
  • 52 Week High
  • SLRN $8.89
  • SIBN $21.70
  • Technical
  • Relative Strength Index (RSI)
  • SLRN 31.17
  • SIBN 38.85
  • Support Level
  • SLRN $4.29
  • SIBN $12.00
  • Resistance Level
  • SLRN $6.19
  • SIBN $12.60
  • Average True Range (ATR)
  • SLRN 0.45
  • SIBN 0.77
  • MACD
  • SLRN -0.20
  • SIBN -0.27
  • Stochastic Oscillator
  • SLRN 6.39
  • SIBN 1.79

About SLRN ACELYRIN INC.

Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of of transformative medicines.

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Share on Social Networks: